Keyphrases
Fluid Overload
79%
Intensive Care Patients
78%
Randomized Clinical Trial
55%
Placebo
53%
Intensive Care Unit
49%
Intensive Care Unit Patients
48%
Furosemide
41%
Septic Shock
39%
Adult Intensive Care Unit
34%
Fluid Removal
34%
Loop Diuretics
30%
Meta-analysis
27%
Clinical Analysis
26%
Goal-directed Fluid
26%
Adult Intensive Care
26%
Blinded Trial
26%
Bioimpedance
26%
Risk Factors
20%
Adult Patients
20%
Fluid Status
19%
Sepsis
17%
Organ Dysfunction
17%
Cumulative Fluid Balance
15%
Intensive Care
15%
Health-related Quality of Life
15%
Cognitive Function
15%
Confidence Interval
14%
Days Alive without Life Support
14%
Critically Ill Patients
14%
Ventilator
14%
Vasopressors
14%
Hypernatremia
14%
COVID-19
13%
Intravenous Fluids
13%
Coronavirus Disease (COVID)
13%
Acute Hypoxemic Respiratory Failure
13%
Oxygenation
13%
Adult-onset Still's Disease
13%
Statistical Analysis Plan
13%
Respiratory Support
13%
Diagnostic Challenge
13%
Oxygenation Targets
13%
Opioid Overdose
13%
Discharge Diagnosis
13%
Selepressin
13%
Hospitalized Adults
13%
Mivacurium
13%
Succinylcholine
13%
Fluid-filled
13%
Butyrylcholinesterase (BChE)
13%
Medicine and Dentistry
Intensive Care Unit
100%
Intensive Care
93%
Hypervolemia
78%
Placebo
42%
Randomized Clinical Trial
42%
Systematic Review
41%
Furosemide
41%
Loop Diuretic Agent
30%
Meta-Analysis
27%
Sequential Analysis
26%
Diagnosis
17%
Fluid Balance
16%
Quality of Life
15%
Cognition
15%
Hypernatremia
14%
Adverse Event
13%
Reproducibility
13%
Septic Shock
13%
COVID-19
13%
Respiratory Failure
13%
Infusion Fluid
13%
Assisted Ventilation
13%
Cohort Analysis
13%
Adult Onset Still Disease
13%
Emergency Care
13%
Mivacurium
13%
Cholinesterase
13%
Suxamethonium
13%
Antibiotics
13%
Multiplex Polymerase Chain Reaction
13%
Retrospective Study
13%
Artificial Respiration
12%
Clinician
10%
Disease
8%
ST Segment Elevation Myocardial Infarction
8%
Hypoxemia
7%
Infusion
5%
All Cause Mortality
5%
Intravenous Drug Administration
5%
Diuretic Agent
5%
Visual Analog Scale
5%
Montreal Cognitive Assessment
5%
Antibiotic Therapy
5%
Pathogen
5%
Nursing and Health Professions
Hypervolemia
65%
Intensive Care
65%
Intensive Care Unit
53%
Placebo
42%
Furosemide
41%
Systematic Review
41%
Loop Diuretic Agent
28%
Meta Analysis
27%
Sequential Analysis
26%
Reproducibility
13%
Cohort Analysis
13%
Hypernatremia
13%
Confidence Interval
9%
Randomization
9%
Gold Standard
8%
Adverse Event
8%
Medline
5%
Embase
5%
All Cause Mortality
5%